Original Benoquin For Vitiligo 0300-0378807 Buynow!

Benoquin Monobenzone for Vitiligo in Pakistan 0300-0378807

Benoquin (Monobenzone) is a topical depigmenting medicine used in selected cases of extensive vitiligo to reduce the contrast between areas of normal pigmented skin and existing depigmented patches. Its active ingredient, monobenzyl ether of hydroquinone (MBEH), works by causing a lasting loss of melanin-producing melanocytes.

What Is Benoquin Monobenzone?

Benoquin contains monobenzone, a potent depigmenting agent. Unlike ordinary skin-lightening ingredients, monobenzone is intended for permanent depigmentation and is therefore not a routine cosmetic whitening cream.

For people with widespread vitiligo, a dermatologist may consider depigmentation when repigmentation treatments have not provided satisfactory results.

Benoquin for Vitiligo

Depigmentation therapy may be considered for people with extensive vitiligo, particularly when a large proportion of the skin has already lost pigmentation. The goal is to make remaining pigmented areas closer in appearance to the existing white patches.

Treatment can be slow, and the final result may be uneven or incomplete. DermNet notes that depigmentation can take several months and, in some areas, up to a year.

Important Benefits

Designed for depigmentation in extensive vitiligo
Helps reduce the contrast between pigmented and depigmented skin
Can provide long-lasting or permanent depigmentation
May be considered when conventional vitiligo repigmentation treatments have failed
Particularly relevant to extensive vitiligo affecting exposed areas

Who Should Use Benoquin?

Benoquin should not be treated as a general skin-whitening product. Monobenzone can permanently remove pigmentation and may cause depigmentation in areas beyond where it is applied. It is generally considered for carefully selected people with extensive vitiligo under dermatological supervision.

People who are pregnant or breastfeeding should discuss its use with a healthcare professional because adequate safety information is not available. Safety in children under 12 has also not been established.